arrow_back Back Filing freshness 10-Q Q2 FY2026 SEC EDGAR

download Export Data

4D Molecular Therapeutics, Inc.

FDMT

$11.26 ▼ -1.02 (-8.31%) at close

28 Visible periods

29 Metrics

Peer-ranked Benchmarks

Price Chart

Health

Poor

Bearish

auto_awesome

Analytical Summary

4D Molecular Therapeutics, Inc. faces fundamental challenges with weakness in Return on Common Equity (%) and Profit Margin (%). The fundamentals warrant careful consideration of downside risks.

Market Cap $791.3M

Dividend Yield —

Revenue Growth 25106.7% ↗

Op. Margin None

ROIC -14.2% ↘

FCF / Share $-1.00 →

Trailing P/E —

Price / Book 1.5x

FCF Yield —

Debt / Equity 0.05

info Valuation on last close. End-of-day price, Nov 5, 2026.

28-Year Financial Trajectory

Quarterly

Metric Value Trend Year over Year Percentile

Revenue Total top-line sales

$3.78M

↑ +25106.7% —

Net Income Profit after all expenses

$-68.76M

↓ -43.3% —

Operating Margin Operating profit as % of sales

17.3%

↑ +125.0% 0th

FCF / Share Free cash flow per share

$-1.00

↓ -28.2% —

trending_up

Bullish Indicators

No bullish signals detected.

warning

Bearish Risks

Operating Margin (%)Operating Margin (%) is in the bottom quartile
Profit Margin (%)Profit Margin (%) is in the bottom quartile
Return on Common Equity (%)Return on Common Equity (%) is in the bottom quartile

Health Breakdown

Profitability ↑

Returns ↓

Cash Quality ↓

Financial view

Statement lens

Choose the reporting cadence, isolate a period range, or search directly for a metric.

Cadence

Annual Quarterly

Range

→

📈 Is growth accelerating? 6 metrics

Metric	Q2 FY2026 Jun 30, 2026 10-Q ↗	Q1 FY2026 Mar 31, 2026 10-Q ↗	Q4 FY2025 Dec 31, 2025 10-K ↗	Q3 FY2025 Sep 30, 2025 10-Q ↗	Q2 FY2025 Jun 30, 2025 10-Q ↗	Q1 FY2025 Mar 31, 2025 10-Q ↗	Q4 FY2024 Dec 31, 2024 10-K ↗	Q3 FY2024 Sep 30, 2024 10-Q ↗	Q2 FY2024 Jun 30, 2024 10-Q ↗	Q1 FY2024 Mar 31, 2024 10-Q ↗	Q4 FY2023 Dec 31, 2023 10-K ↗	Q3 FY2023 Sep 30, 2023 10-Q ↗	Q2 FY2023 Jun 30, 2023 10-Q ↗	Q1 FY2023 Mar 31, 2023 10-Q ↗	Q4 FY2022 Dec 31, 2022 10-K ↗	Q3 FY2022 Sep 30, 2022 10-Q ↗	Q2 FY2022 Jun 30, 2022 10-Q ↗	Q1 FY2022 Mar 31, 2022 10-Q ↗	Q4 FY2021 Dec 31, 2021 10-K ↗	Q3 FY2021 Sep 30, 2021 10-Q ↗	Q2 FY2021 Jun 30, 2021 10-Q ↗	Q1 FY2021 Mar 31, 2021 10-Q ↗	Q4 FY2020 Dec 31, 2020 10-K ↗	Q3 FY2020 Sep 30, 2020 10-Q ↗	Q2 FY2020 Jun 30, 2020 10-Q ↗	Q1 FY2020 Mar 31, 2020 10-Q ↗	Q4 FY2019 Dec 31, 2019 10-K ↗	Q4 FY2018 Dec 31, 2018 10-K ↗
Revenue Growth YoY (%)	25106.7% Excellent ↓ Excellent Declining Year-over-year change in total revenue Optimal: > 10% vs Sector: Above avg (+313733%)	21664.3% Excellent ↓ Excellent Declining Year-over-year change in total revenue Optimal: > 10% vs Sector: Above avg (+270704%)	8508900.0% Excellent ↑ Excellent Improving Year-over-year change in total revenue Optimal: > 10% vs Sector: Above avg (+106361150%)	2900.0% Excellent ↑ Excellent Improving Year-over-year change in total revenue Optimal: > 10% vs Sector: Above avg (+36150%)	200.0% Excellent ↑ Excellent Improving Year-over-year change in total revenue Optimal: > 10% vs Sector: Above avg (+2400%)	-50.0% Weak ↑ Weak Improving Year-over-year change in total revenue Optimal: > 10% vs Sector: Below avg (-725%)	N/M	-100.0% Weak ↓ Weak Declining Year-over-year change in total revenue Optimal: > 10% vs Sector: Below avg (-1350%)	-97.9% Weak ↓ Weak Declining Year-over-year change in total revenue Optimal: > 10% vs Sector: Below avg (-1324%)	-90.6% Weak ↓ Weak Declining Year-over-year change in total revenue Optimal: > 10% vs Sector: Below avg (-1233%)	N/M	3940.8% Excellent ↑ Excellent Improving Year-over-year change in total revenue Optimal: > 10% vs Sector: Above avg (+49160%)	47.5% Excellent ↓ Excellent Declining Year-over-year change in total revenue Optimal: > 10% vs Sector: Above avg (+494%)	-75.6% Weak ↓ Weak Declining Year-over-year change in total revenue Optimal: > 10% vs Sector: Below avg (-1044%)	1255.4% Excellent ↑ Excellent Improving Year-over-year change in total revenue Optimal: > 10% vs Sector: Above avg (+15593%)	-63.4% Weak ↑ Weak Improving Year-over-year change in total revenue Optimal: > 10% vs Sector: Below avg (-892%)	-98.9% Weak ↓ Weak Declining Year-over-year change in total revenue Optimal: > 10% vs Sector: Below avg (-1336%)	-39.1% Weak ↓ Weak Declining Year-over-year change in total revenue Optimal: > 10% vs Sector: Below avg (-588%)	N/M	-81.6% Weak ↓ Weak Declining Year-over-year change in total revenue Optimal: > 10% vs Sector: Below avg (-1120%)	301.3% Excellent Excellent Year-over-year change in total revenue Optimal: > 10% vs Sector: Above avg (+3667%)	-43.4% Weak Weak Year-over-year change in total revenue Optimal: > 10% vs Sector: Below avg (-643%)	—	—	—	—	—	—
EPS Growth YoY (%)	-6.1% Weak ↑ Weak Improving Year-over-year change in earnings per share Optimal: > 10%	-17.4% Weak ↑ Weak Improving Year-over-year change in earnings per share Optimal: > 10%	N/M	-27.8% Weak ↑ Weak Improving Year-over-year change in earnings per share Optimal: > 10%	-55.6% Weak ↑ Weak Improving Year-over-year change in earnings per share Optimal: > 10%	-30.3% Weak ↑ Weak Improving Year-over-year change in earnings per share Optimal: > 10%	-16.9% Weak ↑ Weak Improving Year-over-year change in earnings per share Optimal: > 10%	-229.2% Weak ↓ Weak Declining Year-over-year change in earnings per share Optimal: > 10%	18.2% Good ↓ Good Declining Year-over-year change in earnings per share Optimal: > 10%	25.0% Good ↓ Good Declining Year-over-year change in earnings per share Optimal: > 10%	8.3% Fair ↓ Fair Declining Year-over-year change in earnings per share Optimal: > 10%	69.6% Excellent ↑ Excellent Improving Year-over-year change in earnings per share Optimal: > 10%	11.5% Fair ↑ Fair Improving Year-over-year change in earnings per share Optimal: > 10%	—	1.2% Caution ↑ Caution Improving Year-over-year change in earnings per share Optimal: > 10%	3.7% Caution Caution Year-over-year change in earnings per share Optimal: > 10%	-210.7% Weak Weak Year-over-year change in earnings per share Optimal: > 10%	—	—	—	—	—	—	—	—	—	—	—
Net Income Growth YoY (%)	-43.3% Weak ↑ Weak Improving Year-over-year change in net income	-43.3% Weak ↑ Weak Improving Year-over-year change in net income	N/M	-48.1% Weak → Weak Stable Year-over-year change in net income	-48.1% Weak ↓ Weak Declining Year-over-year change in net income	-48.1% Weak ↓ Weak Declining Year-over-year change in net income	-53.9% Weak ↓ Weak Declining Year-over-year change in net income	-13.0% Weak ↑ Weak Improving Year-over-year change in net income	-13.0% Weak → Weak Stable Year-over-year change in net income	-13.0% Weak ↓ Weak Declining Year-over-year change in net income	-17.9% Weak ↓ Weak Declining Year-over-year change in net income	-8.9% Weak → Weak Stable Year-over-year change in net income	-8.9% Weak ↑ Weak Improving Year-over-year change in net income	-8.9% Weak ↑ Weak Improving Year-over-year change in net income	-9.2% Weak ↑ Weak Improving Year-over-year change in net income	-60.5% Weak ↓ Weak Declining Year-over-year change in net income	-60.5% Weak ↓ Weak Declining Year-over-year change in net income	-60.5% Weak ↓ Weak Declining Year-over-year change in net income	-22.1% Weak ↑ Weak Improving Year-over-year change in net income	-24.7% Weak → Weak Stable Year-over-year change in net income	-24.7% Weak Weak Year-over-year change in net income	-24.7% Weak Weak Year-over-year change in net income	—	—	—	—	—	—
FCF Growth YoY (%)	-28.2% Weak Weak Year-over-year change in free cash flow	-15.3% Weak Weak Year-over-year change in free cash flow	—	—	—	-43.5% Weak Weak Year-over-year change in free cash flow	—	—	—	31.6% Excellent Excellent Year-over-year change in free cash flow	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—
Revenue CAGR 3Y (%)	151.0% Excellent ↑ Excellent Improving Compound annual revenue growth over 3 years	117.0% Excellent ↑ Excellent Improving Compound annual revenue growth over 3 years	308.6% Excellent ↑ Excellent Improving Compound annual revenue growth over 3 years	-43.5% Weak ↑ Weak Improving Compound annual revenue growth over 3 years	-54.8% Weak ↑ Weak Improving Compound annual revenue growth over 3 years	-77.4% Weak ↑ Weak Improving Compound annual revenue growth over 3 years	-77.8% Weak ↑ Weak Improving Compound annual revenue growth over 3 years	-87.0% Weak → Weak Stable Compound annual revenue growth over 3 years	-93.0% Weak ↓ Weak Declining Compound annual revenue growth over 3 years	-75.9% Weak ↓ Weak Declining Compound annual revenue growth over 3 years	—	39.6% Excellent ↑ Excellent Improving Compound annual revenue growth over 3 years	-59.6% Weak Weak Compound annual revenue growth over 3 years	-56.2% Weak Weak Compound annual revenue growth over 3 years	—	—	—	—	—	—	—	—	—	—	—	—	—	—
Revenue CAGR 5Y (%)	-23.7% Weak ↑ Weak Improving Compound annual revenue growth over 5 years	8.8% Good ↑ Good Improving Compound annual revenue growth over 5 years	—	-58.6% Weak ↑ Weak Improving Compound annual revenue growth over 5 years	-66.6% Weak Weak Compound annual revenue growth over 5 years	-66.9% Weak Weak Compound annual revenue growth over 5 years	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—

💰 Are margins durable? 4 metrics

Metric	Q2 FY2026 Jun 30, 2026 10-Q ↗	Q1 FY2026 Mar 31, 2026 10-Q ↗	Q4 FY2025 Dec 31, 2025 10-K ↗	Q3 FY2025 Sep 30, 2025 10-Q ↗	Q2 FY2025 Jun 30, 2025 10-Q ↗	Q1 FY2025 Mar 31, 2025 10-Q ↗	Q4 FY2024 Dec 31, 2024 10-K ↗	Q3 FY2024 Sep 30, 2024 10-Q ↗	Q2 FY2024 Jun 30, 2024 10-Q ↗	Q1 FY2024 Mar 31, 2024 10-Q ↗	Q4 FY2023 Dec 31, 2023 10-K ↗	Q3 FY2023 Sep 30, 2023 10-Q ↗	Q2 FY2023 Jun 30, 2023 10-Q ↗	Q1 FY2023 Mar 31, 2023 10-Q ↗	Q4 FY2022 Dec 31, 2022 10-K ↗	Q3 FY2022 Sep 30, 2022 10-Q ↗	Q2 FY2022 Jun 30, 2022 10-Q ↗	Q1 FY2022 Mar 31, 2022 10-Q ↗	Q4 FY2021 Dec 31, 2021 10-K ↗	Q3 FY2021 Sep 30, 2021 10-Q ↗	Q2 FY2021 Jun 30, 2021 10-Q ↗	Q1 FY2021 Mar 31, 2021 10-Q ↗	Q4 FY2020 Dec 31, 2020 10-K ↗	Q3 FY2020 Sep 30, 2020 10-Q ↗	Q2 FY2020 Jun 30, 2020 10-Q ↗	Q1 FY2020 Mar 31, 2020 10-Q ↗	Q4 FY2019 Dec 31, 2019 10-K ↗	Q4 FY2018 Dec 31, 2018 10-K ↗
Operating Margin (%) (%)	—	—	17.3% Fair Fair Operating income as a percentage of revenue Optimal: > 15% vs Sector: Above avg (+15%)	—	—	—	—	—	—	—	—	-69.2% Weak Weak Operating income as a percentage of revenue Optimal: > 15% vs Sector: Below avg (-561%)	—	—	—	—	—	—	—	—	-52.1% Weak Weak Operating income as a percentage of revenue Optimal: > 15% vs Sector: Below avg (-447%)	—	—	-105.3% Weak ↑ Weak Improving Operating income as a percentage of revenue Optimal: > 15% vs Sector: Below avg (-802%)	-417.0% Weak Weak Operating income as a percentage of revenue Optimal: > 15% vs Sector: Below avg (-2880%)	-375.6% Weak Weak Operating income as a percentage of revenue Optimal: > 15% vs Sector: Below avg (-2604%)	—	—
Profit Margin (%) (%)	—	—	22.8% Excellent Excellent Net income as a percentage of revenue Optimal: > 15% vs Sector: Above avg (+90%)	—	—	—	—	—	—	—	—	-142.0% Weak Weak Net income as a percentage of revenue Optimal: > 15% vs Sector: Below avg (-1283%)	—	—	—	—	—	—	—	—	-112.5% Weak Weak Net income as a percentage of revenue Optimal: > 15% vs Sector: Below avg (-1038%)	—	—	-177.3% Weak ↑ Weak Improving Net income as a percentage of revenue Optimal: > 15% vs Sector: Below avg (-1578%)	-362.2% Weak Weak Net income as a percentage of revenue Optimal: > 15% vs Sector: Below avg (-3119%)	-372.3% Weak Weak Net income as a percentage of revenue Optimal: > 15% vs Sector: Below avg (-3202%)	—	—
FCF Margin (%) (%)	—	—	33.5% Excellent Excellent Free cash flow as a percentage of revenue Optimal: > 10%	—	—	—	—	—	—	—	—	-7.8% Weak Weak Free cash flow as a percentage of revenue Optimal: > 10%	—	—	—	—	—	—	—	—	-116.2% Weak Weak Free cash flow as a percentage of revenue Optimal: > 10%	—	—	-184.9% Weak ↑ Weak Improving Free cash flow as a percentage of revenue Optimal: > 10%	-173.1% Weak Weak Free cash flow as a percentage of revenue Optimal: > 10%	-412.8% Weak Weak Free cash flow as a percentage of revenue Optimal: > 10%	—	—
FCF / Net Income (x)	1.02x Fair ↓ Fair Declining Free cash flow relative to reported net income Optimal: > 1x	0.99x Caution ↓ Caution Declining Free cash flow relative to reported net income Optimal: > 1x	1.47x Good ↑ Good Improving Free cash flow relative to reported net income Optimal: > 1x	0.97x Caution → Caution Stable Free cash flow relative to reported net income Optimal: > 1x	0.91x Caution ↓ Caution Declining Free cash flow relative to reported net income Optimal: > 1x	1.01x Fair Fair Free cash flow relative to reported net income Optimal: > 1x	0.94x Caution Caution Free cash flow relative to reported net income Optimal: > 1x	—	—	0.92x Caution ↑ Caution Improving Free cash flow relative to reported net income Optimal: > 1x	0.78x Caution ↑ Caution Improving Free cash flow relative to reported net income Optimal: > 1x	0.05x Weak ↓ Weak Declining Free cash flow relative to reported net income Optimal: > 1x	0.80x Caution ↓ Caution Declining Free cash flow relative to reported net income Optimal: > 1x	1.01x Fair Fair Free cash flow relative to reported net income Optimal: > 1x	0.85x Caution Caution Free cash flow relative to reported net income Optimal: > 1x	—	—	1.14x Fair ↑ Fair Improving Free cash flow relative to reported net income Optimal: > 1x	1.07x Fair → Fair Stable Free cash flow relative to reported net income Optimal: > 1x	1.12x Fair ↑ Fair Improving Free cash flow relative to reported net income Optimal: > 1x	1.03x Fair ↑ Fair Improving Free cash flow relative to reported net income Optimal: > 1x	0.98x Caution ↑ Caution Improving Free cash flow relative to reported net income Optimal: > 1x	0.88x Caution → Caution Stable Free cash flow relative to reported net income Optimal: > 1x	1.04x Fair ↑ Fair Improving Free cash flow relative to reported net income Optimal: > 1x	0.48x Weak Weak Free cash flow relative to reported net income Optimal: > 1x	1.11x Fair Fair Free cash flow relative to reported net income Optimal: > 1x	—	—

🎯 Is capital allocation efficient? 3 metrics

Metric	Q2 FY2026 Jun 30, 2026 10-Q ↗	Q1 FY2026 Mar 31, 2026 10-Q ↗	Q4 FY2025 Dec 31, 2025 10-K ↗	Q3 FY2025 Sep 30, 2025 10-Q ↗	Q2 FY2025 Jun 30, 2025 10-Q ↗	Q1 FY2025 Mar 31, 2025 10-Q ↗	Q4 FY2024 Dec 31, 2024 10-K ↗	Q3 FY2024 Sep 30, 2024 10-Q ↗	Q2 FY2024 Jun 30, 2024 10-Q ↗	Q1 FY2024 Mar 31, 2024 10-Q ↗	Q4 FY2023 Dec 31, 2023 10-K ↗	Q3 FY2023 Sep 30, 2023 10-Q ↗	Q2 FY2023 Jun 30, 2023 10-Q ↗	Q1 FY2023 Mar 31, 2023 10-Q ↗	Q4 FY2022 Dec 31, 2022 10-K ↗	Q3 FY2022 Sep 30, 2022 10-Q ↗	Q2 FY2022 Jun 30, 2022 10-Q ↗	Q1 FY2022 Mar 31, 2022 10-Q ↗	Q4 FY2021 Dec 31, 2021 10-K ↗	Q3 FY2021 Sep 30, 2021 10-Q ↗	Q2 FY2021 Jun 30, 2021 10-Q ↗	Q1 FY2021 Mar 31, 2021 10-Q ↗	Q4 FY2020 Dec 31, 2020 10-K ↗	Q3 FY2020 Sep 30, 2020 10-Q ↗	Q2 FY2020 Jun 30, 2020 10-Q ↗	Q1 FY2020 Mar 31, 2020 10-Q ↗	Q4 FY2019 Dec 31, 2019 10-K ↗	Q4 FY2018 Dec 31, 2018 10-K ↗
Return on Invested Capital (%)	-14.2% Weak ↓ Weak Declining Return earned on debt + equity capital invested Optimal: > 10%	-12.9% Weak ↓ Weak Declining Return earned on debt + equity capital invested Optimal: > 10%	2.3% Weak ↑ Weak Improving Return earned on debt + equity capital invested Optimal: > 10%	-13.1% Weak ↓ Weak Declining Return earned on debt + equity capital invested Optimal: > 10%	-11.2% Weak ↓ Weak Declining Return earned on debt + equity capital invested Optimal: > 10%	-9.0% Weak ↓ Weak Declining Return earned on debt + equity capital invested Optimal: > 10%	-8.7% Weak ↓ Weak Declining Return earned on debt + equity capital invested Optimal: > 10%	-7.3% Weak ↓ Weak Declining Return earned on debt + equity capital invested Optimal: > 10%	-5.7% Weak → Weak Stable Return earned on debt + equity capital invested Optimal: > 10%	-5.0% Weak ↑ Weak Improving Return earned on debt + equity capital invested Optimal: > 10%	-9.4% Weak ↓ Weak Declining Return earned on debt + equity capital invested Optimal: > 10%	-3.3% Weak ↑ Weak Improving Return earned on debt + equity capital invested Optimal: > 10%	-7.8% Weak ↑ Weak Improving Return earned on debt + equity capital invested Optimal: > 10%	-10.9% Weak ↓ Weak Declining Return earned on debt + equity capital invested Optimal: > 10%	-9.8% Weak ↓ Weak Declining Return earned on debt + equity capital invested Optimal: > 10%	-8.3% Weak ↓ Weak Declining Return earned on debt + equity capital invested Optimal: > 10%	-8.2% Weak ↓ Weak Declining Return earned on debt + equity capital invested Optimal: > 10%	-7.0% Weak ↓ Weak Declining Return earned on debt + equity capital invested Optimal: > 10%	-6.1% Weak ↓ Weak Declining Return earned on debt + equity capital invested Optimal: > 10%	-8.0% Weak ↓ Weak Declining Return earned on debt + equity capital invested Optimal: > 10%	-2.5% Weak ↓ Weak Declining Return earned on debt + equity capital invested Optimal: > 10%	-5.3% Weak ↓ Weak Declining Return earned on debt + equity capital invested Optimal: > 10%	-6.3% Weak ↓ Weak Declining Return earned on debt + equity capital invested Optimal: > 10%	5.9% Caution ↓ Caution Declining Return earned on debt + equity capital invested Optimal: > 10%	12.1% Good Good Return earned on debt + equity capital invested Optimal: > 10%	12.3% Good Good Return earned on debt + equity capital invested Optimal: > 10%	—	—
Return on Capital (%) (%)	-15.6% Weak ↓ Weak Declining Operating profit relative to total assets Optimal: > 10%	-14.4% Weak ↓ Weak Declining Operating profit relative to total assets Optimal: > 10%	2.6% Weak ↑ Weak Improving Operating profit relative to total assets Optimal: > 10%	-14.4% Weak ↓ Weak Declining Operating profit relative to total assets Optimal: > 10%	—	-10.4% Weak ↓ Weak Declining Operating profit relative to total assets Optimal: > 10%	-10.0% Weak ↓ Weak Declining Operating profit relative to total assets Optimal: > 10%	-8.5% Weak ↓ Weak Declining Operating profit relative to total assets Optimal: > 10%	-6.8% Weak ↑ Weak Improving Operating profit relative to total assets Optimal: > 10%	-6.1% Weak Weak Operating profit relative to total assets Optimal: > 10%	-10.8% Weak Weak Operating profit relative to total assets Optimal: > 10%	—	—	-12.3% Weak ↓ Weak Declining Operating profit relative to total assets Optimal: > 10%	-11.0% Weak ↓ Weak Declining Operating profit relative to total assets Optimal: > 10%	-9.5% Weak ↓ Weak Declining Operating profit relative to total assets Optimal: > 10%	-9.4% Weak ↓ Weak Declining Operating profit relative to total assets Optimal: > 10%	-8.1% Weak Weak Operating profit relative to total assets Optimal: > 10%	-7.0% Weak Weak Operating profit relative to total assets Optimal: > 10%	—	—	-6.0% Weak Weak Operating profit relative to total assets Optimal: > 10%	-7.1% Weak Weak Operating profit relative to total assets Optimal: > 10%	—	—	—	—	—
Return on Common Equity (%) (%)	-16.9% Weak ↓ Weak Declining Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-212%)	-15.2% Weak ↓ Weak Declining Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-201%)	3.8% Weak ↑ Weak Improving Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-74%)	-13.0% Weak ↓ Weak Declining Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-187%)	-11.4% Weak ↓ Weak Declining Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-176%)	-10.2% Weak ↓ Weak Declining Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-168%)	-9.7% Weak ↓ Weak Declining Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-165%)	-5.9% Weak ↑ Weak Improving Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-139%)	-5.5% Weak ↑ Weak Improving Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-137%)	-5.4% Weak ↑ Weak Improving Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-136%)	-10.5% Weak → Weak Stable Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-170%)	-8.7% Weak ↑ Weak Improving Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-158%)	-8.8% Weak ↑ Weak Improving Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-159%)	-13.1% Weak ↓ Weak Declining Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-187%)	-11.8% Weak ↓ Weak Declining Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-179%)	-10.5% Weak ↓ Weak Declining Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-170%)	-9.7% Weak ↓ Weak Declining Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-164%)	-8.9% Weak ↓ Weak Declining Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-159%)	-7.9% Weak ↓ Weak Declining Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-152%)	-7.3% Weak → Weak Stable Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-149%)	-6.8% Weak ↓ Weak Declining Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-145%)	-6.8% Weak ↓ Weak Declining Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-145%)	-8.0% Weak ↓ Weak Declining Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-153%)	12.5% Fair ↓ Fair Declining Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-17%)	13.3% Fair Fair Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-12%)	15.5% Good Good Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: At sector avg	—	—

⚖️ Is the balance sheet risky? 3 metrics

Metric	Q2 FY2026 Jun 30, 2026 10-Q ↗	Q1 FY2026 Mar 31, 2026 10-Q ↗	Q4 FY2025 Dec 31, 2025 10-K ↗	Q3 FY2025 Sep 30, 2025 10-Q ↗	Q2 FY2025 Jun 30, 2025 10-Q ↗	Q1 FY2025 Mar 31, 2025 10-Q ↗	Q4 FY2024 Dec 31, 2024 10-K ↗	Q3 FY2024 Sep 30, 2024 10-Q ↗	Q2 FY2024 Jun 30, 2024 10-Q ↗	Q1 FY2024 Mar 31, 2024 10-Q ↗	Q4 FY2023 Dec 31, 2023 10-K ↗	Q3 FY2023 Sep 30, 2023 10-Q ↗	Q2 FY2023 Jun 30, 2023 10-Q ↗	Q1 FY2023 Mar 31, 2023 10-Q ↗	Q4 FY2022 Dec 31, 2022 10-K ↗	Q3 FY2022 Sep 30, 2022 10-Q ↗	Q2 FY2022 Jun 30, 2022 10-Q ↗	Q1 FY2022 Mar 31, 2022 10-Q ↗	Q4 FY2021 Dec 31, 2021 10-K ↗	Q3 FY2021 Sep 30, 2021 10-Q ↗	Q2 FY2021 Jun 30, 2021 10-Q ↗	Q1 FY2021 Mar 31, 2021 10-Q ↗	Q4 FY2020 Dec 31, 2020 10-K ↗	Q3 FY2020 Sep 30, 2020 10-Q ↗	Q2 FY2020 Jun 30, 2020 10-Q ↗	Q1 FY2020 Mar 31, 2020 10-Q ↗	Q4 FY2019 Dec 31, 2019 10-K ↗	Q4 FY2018 Dec 31, 2018 10-K ↗
Debt to Equity (x)	0.05x Excellent Excellent Total debt relative to shareholder equity Optimal: < 0.6x vs Sector: Below avg (-92%)	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—
Net Debt (USD)	$-50.78M	$-72.49M	$-60.24M	$-48.55M	—	$-133.53M	$-149.34M	$-187.54M	$-189.06M	$-275.59M	$-249.11M	—	—	$-78.57M	$-52.35M	$-108.30M	$-113.48M	$-75.97M	$-153.00M	—	—	$-259.87M	$-276.73M	—	—	—	$-49.65M	—
Debt / EBITDA (x)	-0.26x Excellent Excellent Debt relative to earnings before interest, taxes, depreciation Optimal: < 2x	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—

📊 What does each share earn? 6 metrics

Metric	Q2 FY2026 Jun 30, 2026 10-Q ↗	Q1 FY2026 Mar 31, 2026 10-Q ↗	Q4 FY2025 Dec 31, 2025 10-K ↗	Q3 FY2025 Sep 30, 2025 10-Q ↗	Q2 FY2025 Jun 30, 2025 10-Q ↗	Q1 FY2025 Mar 31, 2025 10-Q ↗	Q4 FY2024 Dec 31, 2024 10-K ↗	Q3 FY2024 Sep 30, 2024 10-Q ↗	Q2 FY2024 Jun 30, 2024 10-Q ↗	Q1 FY2024 Mar 31, 2024 10-Q ↗	Q4 FY2023 Dec 31, 2023 10-K ↗	Q3 FY2023 Sep 30, 2023 10-Q ↗	Q2 FY2023 Jun 30, 2023 10-Q ↗	Q1 FY2023 Mar 31, 2023 10-Q ↗	Q4 FY2022 Dec 31, 2022 10-K ↗	Q3 FY2022 Sep 30, 2022 10-Q ↗	Q2 FY2022 Jun 30, 2022 10-Q ↗	Q1 FY2022 Mar 31, 2022 10-Q ↗	Q4 FY2021 Dec 31, 2021 10-K ↗	Q3 FY2021 Sep 30, 2021 10-Q ↗	Q2 FY2021 Jun 30, 2021 10-Q ↗	Q1 FY2021 Mar 31, 2021 10-Q ↗	Q4 FY2020 Dec 31, 2020 10-K ↗	Q3 FY2020 Sep 30, 2020 10-Q ↗	Q2 FY2020 Jun 30, 2020 10-Q ↗	Q1 FY2020 Mar 31, 2020 10-Q ↗	Q4 FY2019 Dec 31, 2019 10-K ↗	Q4 FY2018 Dec 31, 2018 10-K ↗
Revenue per Share (USD)	$0.05	$0.04	—	$0.00	$0.00	$0.00	—	$0.00	$0.00	$0.00	—	$0.48	$0.01	$0.01	—	$0.02	$0.01	—	—	$0.05	$0.55	—	—	—	—	—	—	—
Basic EPS, GAAP (USD)	$-1.04	$-1.01	$0.43	$-1.01	$-0.98	$-0.86	$-0.90	$-0.79	$-0.63	$-0.66	$-0.77	$-0.24	$-0.77	$-0.88	$-0.84	$-0.79	$-0.87	—	$-0.85	$-0.82	$-0.28	—	—	—	—	—	—	—
Free Cash Flow per Share (USD)	$-1.00	$-1.00	—	$-0.83	$-0.78	$-0.87	—	—	—	$-0.60	—	$-0.04	$-0.60	$-0.88	—	—	—	—	—	$-0.68	$-0.63	—	—	—	—	—	—	—
Book Value per Share (USD)	$7.38	$8.64	$8.78	$7.89	$7.53	$10.14	$11.15	$10.63	$11.33	$11.74	$7.15	$7.81	$8.48	$6.58	$7.09	$7.76	$8.42	$9.18	$9.90	$8.29	$9.00	$9.08	$9.61	—	—	—	$-14.09	—
Tangible Book Value per Share (USD)	$7.38	$8.64	$8.78	$7.89	$7.53	$10.14	$11.15	$10.63	$11.33	$11.74	$7.15	$7.81	$8.48	$6.58	$7.09	$7.76	$8.42	$9.18	$9.90	$8.29	$9.00	$9.08	$9.61	—	—	—	$-14.09	—
Basic Weighted Avg Shares (shares)	70.27M	68.06M	—	56.13M	55.93M	55.74M	—	55.55M	55.28M	49.27M	—	42.26M	38.34M	32.72M	—	32.39M	32.32M	—	—	27.02M	26.74M	—	—	—	—	—	—	—

🏦 How resilient is the balance sheet? 3 metrics

Metric	Q2 FY2026 Jun 30, 2026 10-Q ↗	Q1 FY2026 Mar 31, 2026 10-Q ↗	Q4 FY2025 Dec 31, 2025 10-K ↗	Q3 FY2025 Sep 30, 2025 10-Q ↗	Q2 FY2025 Jun 30, 2025 10-Q ↗	Q1 FY2025 Mar 31, 2025 10-Q ↗	Q4 FY2024 Dec 31, 2024 10-K ↗	Q3 FY2024 Sep 30, 2024 10-Q ↗	Q2 FY2024 Jun 30, 2024 10-Q ↗	Q1 FY2024 Mar 31, 2024 10-Q ↗	Q4 FY2023 Dec 31, 2023 10-K ↗	Q3 FY2023 Sep 30, 2023 10-Q ↗	Q2 FY2023 Jun 30, 2023 10-Q ↗	Q1 FY2023 Mar 31, 2023 10-Q ↗	Q4 FY2022 Dec 31, 2022 10-K ↗	Q3 FY2022 Sep 30, 2022 10-Q ↗	Q2 FY2022 Jun 30, 2022 10-Q ↗	Q1 FY2022 Mar 31, 2022 10-Q ↗	Q4 FY2021 Dec 31, 2021 10-K ↗	Q3 FY2021 Sep 30, 2021 10-Q ↗	Q2 FY2021 Jun 30, 2021 10-Q ↗	Q1 FY2021 Mar 31, 2021 10-Q ↗	Q4 FY2020 Dec 31, 2020 10-K ↗	Q3 FY2020 Sep 30, 2020 10-Q ↗	Q2 FY2020 Jun 30, 2020 10-Q ↗	Q1 FY2020 Mar 31, 2020 10-Q ↗	Q4 FY2019 Dec 31, 2019 10-K ↗	Q4 FY2018 Dec 31, 2018 10-K ↗
Working Capital (USD)	$335.28M	$361.96M	$369.15M	$275.27M	—	$305.67M	$405.78M	$481.29M	$533.23M	$519.19M	$277.64M	—	—	$195.76M	$204.78M	$218.91M	$232.19M	$230.96M	$239.94M	—	—	$250.59M	$265.91M	—	—	—	$39.55M	—
LT Debt (USD)	$19.59M	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—
Total Equity (USD)	$407.66M	$451.84M	$505.66M	$368.98M	$420.89M	$469.72M	$510.61M	$552.95M	$588.34M	$600.56M	$307.83M	$329.93M	$325.14M	$218.61M	$231.34M	$251.44M	$272.52M	$296.06M	$319.11M	$224.13M	$240.65M	$242.43M	$256.39M	$-105.29M	$-99.16M	$-85.04M	$-72.97M	$-27.59M

📋 What is driving earnings? 4 metrics

Metric	Q2 FY2026 Jun 30, 2026 10-Q ↗	Q1 FY2026 Mar 31, 2026 10-Q ↗	Q4 FY2025 Dec 31, 2025 10-K ↗	Q3 FY2025 Sep 30, 2025 10-Q ↗	Q2 FY2025 Jun 30, 2025 10-Q ↗	Q1 FY2025 Mar 31, 2025 10-Q ↗	Q4 FY2024 Dec 31, 2024 10-K ↗	Q3 FY2024 Sep 30, 2024 10-Q ↗	Q2 FY2024 Jun 30, 2024 10-Q ↗	Q1 FY2024 Mar 31, 2024 10-Q ↗	Q4 FY2023 Dec 31, 2023 10-K ↗	Q3 FY2023 Sep 30, 2023 10-Q ↗	Q2 FY2023 Jun 30, 2023 10-Q ↗	Q1 FY2023 Mar 31, 2023 10-Q ↗	Q4 FY2022 Dec 31, 2022 10-K ↗	Q3 FY2022 Sep 30, 2022 10-Q ↗	Q2 FY2022 Jun 30, 2022 10-Q ↗	Q1 FY2022 Mar 31, 2022 10-Q ↗	Q4 FY2021 Dec 31, 2021 10-K ↗	Q3 FY2021 Sep 30, 2021 10-Q ↗	Q2 FY2021 Jun 30, 2021 10-Q ↗	Q1 FY2021 Mar 31, 2021 10-Q ↗	Q4 FY2020 Dec 31, 2020 10-K ↗	Q3 FY2020 Sep 30, 2020 10-Q ↗	Q2 FY2020 Jun 30, 2020 10-Q ↗	Q1 FY2020 Mar 31, 2020 10-Q ↗	Q4 FY2019 Dec 31, 2019 10-K ↗	Q4 FY2018 Dec 31, 2018 10-K ↗
Sales/Revenue/Turnover (USD)	$3.78M	$3.05M	$85.09M	$90.00K	$15.00K	$14.00K	$1.00K	$3.00K	$5.00K	$28.00K	$-19.00K	$20.20M	$239.00K	$298.00K	$1.25M	$500.00K	$162.00K	$1.22M	$92.00K	$1.37M	$14.58M	$2.00M	$-977.00K	$7.42M	$3.63M	$3.54M	—	—
Depreciation Expense (USD)	$1.30M	$1.30M	$1.30M	$1.30M	$1.30M	$1.30M	$1.20M	$1.20M	$1.20M	$1.20M	$1.30M	$1.10M	$1.10M	$1.00M	$1.00M	$500.00K	$500.00K	$400.00K	$400.00K	$400.00K	$400.00K	$400.00K	$300.00K	$400.00K	$400.00K	$300.00K	—	—
Net Income, GAAP (USD)	$-68.76M	$-68.76M	$19.40M	$-47.97M	$-47.97M	$-47.97M	$-49.67M	$-32.40M	$-32.40M	$-32.40M	$-32.28M	$-28.68M	$-28.68M	$-28.68M	$-27.38M	$-26.34M	$-26.34M	$-26.34M	$-25.08M	$-16.41M	$-16.41M	$-16.41M	$-20.55M	$-13.16M	$-13.16M	$-13.16M	—	—
Operating Cash Flow (USD)	$-70.00M	$-68.12M	$28.55M	$-46.50M	$-43.38M	$-47.76M	$-45.86M	—	—	$-29.09M	$-24.65M	$-1.17M	$-22.07M	$-27.91M	$-22.21M	—	—	$-23.55M	$-21.84M	$-15.72M	$-16.20M	$-15.37M	$-17.50M	$-13.37M	$-6.17M	$-13.87M	—	—

⌨️ Keyboard Shortcuts

/ Search

Esc Clear

A Annual

Q Quarterly

1-7 Jump to category

R Reset

bar_chart Data from SEC EDGAR XBRL filings

Synced 4 days ago 8 years · 28 quarters

4D Molecular Therapeutics, Inc.

Analytical Summary

28-Year Financial Trajectory

Bullish Indicators

Bearish Risks

Health Breakdown

Statement lens

Benchmark Lens

Signals

Percentile Rankings

Peer Comparison

Compare FDMT with peers